Pyxis Oncology, Inc. (PYXS)
시가총액: 66.28M
국가: United States
산업: #Biotechnology_Pharmaceutical_Preparations
섹터: #Health_Care
홈페이지: https://www.pyxisoncology.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 0.00 / 0.00 / -- / -100.0% / --
2412: 0.00 / 0.00 / -- / -- / --
2409: 0.00 / 0.00 / -- / -- / --
2406: -- / -- / -- / -- / --
2403: 16.15M / -- / -- / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.35 / -0.3293 / -6.3% / -483.3% / 43.5%
2412: -0.62 / -0.3245 / -91.1% / -- / -77.1%
2409: -0.35 / -0.3224 / -8.6% / 37.5% / -20.7%
2406: -0.29 / -0.34 / 14.7% / 29.3% / -383.3%
2403: -0.06 / -- / -- / 88.9% / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 0.0(--) / --(--)
2212: 0.0(--) / -3.65(59.2%)
2112: 0.0(--) / -8.95(-1443.8%)
2012: 0.0(--) / -0.579757(-359.6%)

#PYXS

- 사업요약: Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat cancers. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an investigational novel ADC consisting of human immunogl...

Ideal Power Inc. (IPWR)
시가총액: 43.19M
국가: United States
산업: #Semiconductors
섹터: #Technology
홈페이지: https://www.idealpower.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 12M / 900K / 1233.3% / 15140.2% / 221711.5%
2412: 5.41K / 500K / -98.9% / -- / 876.5%
2409: 554 / 400K / -99.9% / -64.4% / -58.3%
2406: 1.33K / 100K / -98.7% / -99.0% / -98.3%
2403: 78.74K / -- / -- / 11758.3% / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.3 / -0.35 / 14.3% / 23.1% / -3.4%
2412: -0.29 / -0.35 / 17.1% / -- / 6.5%
2409: -0.31 / -0.35 / 11.4% / 29.5% / 0.0%
2406: -0.31 / -0.33 / 6.1% / 16.2% / 20.5%
2403: -0.39 / -- / -- / 4.9% / --

- 연간 매출(YoY%), EPS(YoY%)
2212: 203269.0(-64.7%) / -1.17(-46.2%)
2112: 576399.0(34.6%) / -0.8(63.6%)
2012: 428129.0(--) / -2.2(7.6%)
1912: 0.0(--) / -2.38(--)

#IPWR

- 사업요약: Ideal Power Inc. focuses on the development and commercialization of its bidirectional bipolar junction TRANsistor solid-state switch technology. It also offers SymCool Power Module designed to meet low conduction loss n...

Data Storage Corporation (DTST)
시가총액: 27.67M
국가: United States
산업: #EDP_Services
섹터: #Technology
홈페이지: https://www.dtst.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 8.08M / 8.4M / -3.8% / -1.9% / 26.1%
2412: 6.41M / 6.9M / -7.1% / 3.6% / 10.3%
2409: 5.81M / 6.5M / -10.6% / -3.0% / 18.3%
2406: 4.91M / 6.4M / -23.3% / -16.8% / -40.4%
2403: 8.24M / -- / -- / 19.7% / 33.1%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: 0.1 / 0.11 / -9.1% / 100.0% / 150.0%
2412: 0.04 / 0.03 / 33.3% / -- / 100.0%
2409: 0.02 / 0.01 / 100.0% / 0.0% / 150.0%
2406: -0.04 / 0.03 / -233.3% / -233.3% / -180.0%
2403: 0.05 / -- / -- / 400.0% / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 24.96M(4.6%) / --(--)
2212: 23.87M(60.5%) / -0.64(-2233.3%)
2112: 14.88M(59.6%) / 0.03(50.0%)
2012: 9.32M(--) / 0.02(217.7%)

#DTST

- 사업요약: Data Storage Corporation provides data management and cloud solutions in the United States and internationally. It offers a suite of multi-cloud IT solutions, including cyber security solutions, which comprise ezSecurity, a...

REE Automotive Ltd. (REE)
시가총액: 44.64M
국가: Israel
산업: #Auto_Manufacturing
섹터: #Consumer_Discretionary
홈페이지: https://www.ree.auto

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2412: 12K / 50K / -76.0% / -97.4% / 9.1%
2409: 11K / 750K / -98.5% / -94.8% / -98.5%
2406: 750K / 1.13M / -33.6% / -20.5% / 368.8%
2403: 160.00K / 550.00K / -70.9% / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2412: -0.8 / -0.71 / -12.7% / -- / 68.8%
2409: -2.56 / -0.9933 / -157.7% / -7.1% / -284.3%
2406: -0.6661 / -0.6661 / 0.0% / -- / 70.8%
2403: -2.28 / -1.57 / -45.2% / -- / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 1.61M(--) / -11.32(-3.1%)
2212: 0.0(-100.0%) / -10.98(82.9%)
2112: 6000.0(-98.5%) / -64.34(-628.2%)
2012: 388000.0(--) / -8.834965(--)

#REE

- 사업요약: REE Automotive Ltd. operates as an automotive technology company in France, the United Kingdom, the United States, and internationally. The company offers REEcorner, a compact module that integrates critical vehicle drive components comprising as steering, braking, suspension, powertra...

Abeona Therapeutics Inc. (ABEO)
시가총액: 270.09M
국가: United States
산업: #Biotechnology_Pharmaceutical_Preparations
섹터: #Health_Care
홈페이지: https://www.abeonatherapeutics.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 0.00 / 125K / -100.0% / -- / --
2412: 0.00 / 100K / -100.0% / -- / --
2409: 0.00 / 100K / -100.0% / -- / --
2406: 0.00 / 125K / -100.0% / -100.0% / --
2403: 0.0 / -- / -- / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.24 / -0.37 / 35.1% / 79.3% / -148.0%
2412: 0.5 / -0.35 / 242.9% / -- / 179.4%
2409: -0.63 / -0.3925 / -60.5% / -31.3% / -142.3%
2406: -0.26 / -0.33 / 21.2% / 71.7% / 77.6%
2403: -1.16 / -- / -- / -114.8% / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 3.5M(147.5%) / -2.53(54.2%)
2212: 1.41M(-52.9%) / -5.53(74.3%)
2112: 3.0M(-70.0%) / -21.5(5.5%)
2012: 10.0M(--) / -22.75(--)

#ABEO

- 사업요약: Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered...

Lithium Argentina AG (LAR)
시가총액: 315.95M
국가: Canada
산업: #Metal_Mining
섹터: #Basic_Materials
홈페이지: https://www.lithium-argentina.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 0.00 / 36.75M / -100.0% / -- / --
2412: -- / 48.40M / -- / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.04 / 0.0043 / -1030.2% / -- / -33.3%
2412: -0.03 / 0.1 / -130.0% / -- / --

- 연간 매출(YoY%), EPS(YoY%)

#LAR

- 사업요약: Lithium Argentina AG, a resource and materials company, focuses on advancing lithium projects in Argentina. The company owns interests in the Cauchari-Olaroz project located in Jujuy province; and the Pastos Grandes project located in Salta Province of Argentina. The company was formerly known as Lithium Americas (Argentina) Corp. and changed its name to Lithium Argentina AG in January 2025. Lithium Argentina AG was incorporated in 2007 is headquartered in Zug, Switzerland.

Zenas BioPharma, Inc. (ZBIO)
시가총액: 363.12M
국가: United States
산업: #Biotechnology_Pharmaceutical_Preparations
섹터: #Health_Care
홈페이지: https://zenasbio.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 10M / -- / -- / -- / --
2412: 0.00 / -- / -- / -- / --
2409: 0.00 / -- / -- / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.8 / -- / -- / -- / 18.4%
2412: -0.98 / -- / -- / -- / 80.5%
2409: -5.02 / -- / -- / -- / --

- 연간 매출(YoY%), EPS(YoY%)

#ZBIO

- 사업요약: Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody for various indications, including immunoglobulin G4-related disease, multiple sclerosis, systemic lupus erythematosus, and warm autoimmune hemolytic anemia. The company also develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; ZB001, an anti-insulin-l...

SBC Medical Group Holdings Incorporated (SBC)
시가총액: 348.13M
국가: United States
산업: #Medical_Nursing_Services
섹터: #Health_Care
홈페이지: https://sbc-holdings.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 47.33M / 59.19M / -20.0% / -- / -20.4%
2412: 59.46M / 56M / 6.2% / -- / 12.0%
2409: 53.08M / -- / -- / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: 0.21 / 0.16 / 31.2% / -- / 40.0%
2412: 0.15 / 0.19 / -21.1% / -- / 400.0%
2409: 0.03 / -- / -- / -- / --

- 연간 매출(YoY%), EPS(YoY%)

#SBC

- 사업요약: SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally. The company offers advertising and marketing services; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals and facility rentals; construction and design of franchisee clinics; medical equipment; and medical consumables procurement. It provides IT softwa...

I-Mab (IMAB)
시가총액: 69.52M
국가: China
산업: #Biotechnology_Pharmaceutical_Preparations
섹터: #Health_Care
홈페이지: https://ir.i-mabbiopharma.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 0.00 / 0.00 / -- / -- / --
2412: 0.00 / 0.00 / -- / -- / --
2409: 0.00 / -- / -- / -- / --
2406: 0.00 / 750K / -100.0% / -- / --
2403: 0 / 0 / -- / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.02 / -0.11 / 81.8% / 90.9% / 66.7%
2412: -0.06 / -0.06 / 0.0% / -- / 45.5%
2409: -0.11 / -0.07 / -57.1% / -- / -22.2%
2406: -0.09 / -0.31 / 71.0% / -- / 59.0%
2403: -0.2196 / -0.1231 / -78.4% / -- / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 27.64M(112.5%) / --(--)
2212: -221563000.0(-351.7%) / -30.383(1.0%)
2112: 88.03M(-94.3%) / -30.705(-545.0%)
2012: 1.54B(--) / 6.9(126.9%)

#IMAB

- 사업요약: I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics in the fields of immuno-oncology and immuno-inflammation diseases primarily in the United States. It is developing Uliledlimab, a CD73 neutralizing...

bioAffinity Technologies, Inc. (BIAF)
시가총액: 4.03M
국가: United States
산업: #Biotechnology_Commercial_Physical_and_Biological_Resarch
섹터: #Health_Care
홈페이지: https://www.bioaffinitytech.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 1.85M / 2.62M / -29.4% / -23.1% / -15.9%
2412: 2.2M / 2.65M / -17.0% / -0.6% / -6.4%
2409: 2.35M / 2.54M / -7.5% / 687.3% / -2.1%
2406: 2.4M / 2.1M / 14.3% / 12059.3% / -0.3%
2403: 2.41M / -- / -- / 261180.2% / 8.7%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.16 / -0.17 / 5.9% / 20.0% / 15.8%
2412: -0.19 / -0.14 / -35.7% / -- / -18.8%
2409: -0.16 / -0.1512 / -5.8% / 38.5% / 15.8%
2406: -0.19 / -0.22 / 13.6% / 5.0% / 5.0%
2403: -0.2 / -- / -- / -11.1% / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 2.53M(52627.4%) / --(--)
2212: 4803.0(--) / -1.81(22.0%)
2112: 0.0(--) / -2.319421(13.0%)
2012: 0.0(--) / -2.6649(--)

#BIAF

- 사업요약: bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath ...